Amcor Limited stock is in a trading halt


Trading Halt due to pending acquisition announcement: Amcor Limited’s (ASX: AMC) shares are placed in a trading halt until 8 August 2018, as there is a speculation that the company will announce the all-stock acquisition of U.S. rival Bemis Co for the consideration of $7 billion. After acquisition, the company plans to list in the US also. Currently, the packaging industry is facing challenging environment due to the rising cost of inputs, which is prompting companies to hike prices.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

AMC expects additional unfavourable lag in H2 18 of more than around $15million due to rise in raw material cost. Meanwhile, Bemis provides packaging to a range of industries like food, healthcare and consumer goods etc and has a market value of approximately $US4.20 billion. Bemis operates 57 packaging plants in 12 countries, with most of its operations and about 70% of its sales revenue comes from US. On the other hand, AMC stock has risen 14.80% in three months as on August 03, 2018  and is trading at a P/E of 22.03x. AMC stock is added to S&P/ASX 20 Index, effective from June 18, 2018.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report